Literature DB >> 31228169

Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.

Ehsan Mazloumi1, Jalal Poorolajal2, Nizal Sarrafzadegan3,4, Hamid Reza Roohafza4, Javad Faradmal5, Manoochehr Karami6,7.   

Abstract

INTRODUCTION: Contribution of risk factors for cardiovascular-related deaths in the Eastern Mediterranean Region Organization (EMRO) is not estimated quantitatively. AIM: To determine the avoidable burden of cardiovascular diseases (CVDs) due to hypertension, diabetes, smoking, overweight, and obesity in countries of EMRO of the WHO.
METHODS: The comparative risk assessment methodology was used to calculate the potential impact fraction (PIF) and percentage of the avoidable burden of CVD-related death due to associated risk factors. Population exposure levels for CVDs and corresponding measures of association were extracted from published studies. The attributable burden was calculated by multiplying the Disability-Adjusted Life-Years (DALYs) for CVDs by the estimated impact fraction of risk factors. DALYs of the CVDs in all countries of the EMRO were extracted from the GBD official website in 2016.
RESULTS: Following reduction of the current prevalence of smoking, obesity, hypertension, diabetes, and overweight to a feasible minimum risk exposure level in Lebanon, about 12.4%, 4.2%, 10.2%, 3.8%, and 5.7% of the burden of CVD-related mortality could be avoidable, respectively. The corresponding values of avoidable burden in selected EMRO countries were 5.1%, 3.5%, 9.4%, 5.9% and 5.3% in Iran and 9.5%, 4.1%, 11%, 8.2% and 5.4% in Egypt.
CONCLUSIONS: Findings suggest that health policy makers of all EMRO countries should take into account the attributable burden of CVD-related mortality due to associated risk factors to effectively develop preventive interventions.

Entities:  

Keywords:  Cardiovascular diseases; Global burden of diseases; Noncommunicable diseases; Risk factors

Mesh:

Year:  2019        PMID: 31228169     DOI: 10.1007/s40292-019-00319-3

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  22 in total

1.  Blood pressure and stroke: an overview of published reviews.

Authors:  Carlene M M Lawes; Derrick A Bennett; Valery L Feigin; Anthony Rodgers
Journal:  Stroke       Date:  2004-04       Impact factor: 7.914

2.  Estimating the generalized impact fraction from case-control data.

Authors:  K Drescher; H Becher
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

3.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

4.  Mortality attributable to cardiovascular risk factors in Spain.

Authors:  J R Banegas; F Rodríguez-Artalejo; A Graciani; F Villar; R Herruzo
Journal:  Eur J Clin Nutr       Date:  2003-09       Impact factor: 4.016

5.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

6.  Prevalence and Clustering of Cardiovascular Disease Risk Factors among Tibetan Adults in China: A Population-Based Study.

Authors:  Shaopeng Xu; Zepei Jiayong; Bin Li; Hong Zhu; Hong Chang; Wei Shi; Zhengxuan Gao; Xianjia Ning; Jinghua Wang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

7.  Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Authors:  Nizal Sarrafzadegan; Razieh Hassannejad; Hamid Reza Marateb; Mohammad Talaei; Masoumeh Sadeghi; Hamid Reza Roohafza; Farzad Masoudkabir; Shahram Oveisgharan; Marjan Mansourian; Mohammad Reza Mohebian; Miquel Angel Mañanas
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

8.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

9.  Estimation of the Disease Burden Attributable to 11 Risk Factors in Hubei Province, China: A Comparative Risk Assessment.

Authors:  Fangfang Cui; Lan Zhang; Chuanhua Yu; Songbo Hu; Yunquan Zhang
Journal:  Int J Environ Res Public Health       Date:  2016-09-23       Impact factor: 3.390

10.  Estimating the potential impact fraction of hypertension as the main risk factor of stroke: Application of the distribution shift method.

Authors:  Azam Biderafsh; Manoochehr Karami; Javad Faradmal; Jalal Poorolajal
Journal:  J Epidemiol Glob Health       Date:  2015-01-20
View more
  3 in total

1.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

2.  Prevalence of hypertension and associated factors in female prison correctional officers in a national sample in Brazil.

Authors:  Ana Zaira da Silva; Rosa Maria Salani Mota; Raimunda Hermelinda Maia Macena; Roberto da Justa Pires Neto; Marcelo José Monteiro Ferreira; Priscila França de Araújo; Thereza Maria Magalhães Moreira; David W Seal; Carl Kendall; Ligia Regina Franco Sansigolo Kerr
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

3.  Prevalence of hypertension in Ghanaian society: a systematic review, meta-analysis, and GRADE assessment.

Authors:  Fidelis Atibila; Gill Ten Hoor; Emmanuel Timmy Donkoh; Abdul Iddrisu Wahab; Gerjo Kok
Journal:  Syst Rev       Date:  2021-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.